pathology microbiology and immunology

June 2, 2016

VUMC researchers seek to crack the code of neonatal sepsis

Sepsis, an exaggerated and overwhelming inflammatory response to infection, is a major worldwide killer of babies in the first four weeks of life (neonatal period).

By Bill Snyder
May 26, 2016

Wound healing society honors VUMC’s Davidson

Jeff Davidson, Ph.D., professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center, was honored last month at the joint 27th annual Symposium on Advanced Wound Care and Wound Healing Society meeting in Atlanta for “outstanding lifetime achievement in wound healing.”

By Bill Snyder
April 29, 2016

Improving natural killer cancer therapy

A newly discovered mechanism that helps cancer cells avoid destruction by immune system cells may improve immunotherapies.

By Sanjay Mishra
April 28, 2016

An Argonaute’s voyage to cancer

A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

By Bill Snyder
April 5, 2016

Immune defenses in asthma

Vanderbilt researchers show that a certain factor negatively impacts the first-line responder cells in the lungs, providing one explanation for why patients with asthma are at greater risk for invasive bacterial disease.

By Leigh MacMillan
February 4, 2016

Zutter takes part in cancer strategy meet at White House

Vanderbilt physician/scientist Mary Zutter, M.D., Louise B. McGavock Professor of Pathology, Microbiology and Immunology and assistant vice chancellor for Integrative Diagnostics, can now add “White House guest” to her resume.

By VUMC News and Communications
January 27, 2016

Study identifies new culprit in lung cancer development

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.
By Leigh MacMillan
January 14, 2016

Crystal structure reveals secrets of virulent bacterium

Researchers at Vanderbilt University Medical Center have obtained the crystal structure of a toxin from the bacterium Clostridium difficile (“C. diff”) — the leading cause of hospital-acquired diarrhea in the United States.
By Bill Snyder
January 7, 2016

College of American Pathologists lauds Washington’s contributions

Mary (Kay) Washington, M.D., Ph.D., professor of Pathology, Microbiology and Immunology, has received the Lifetime Achievement Award from the College of American Pathologists (CAP). Washington was one of eight physician members honored during the organization’s recent annual meeting.
By VUMC News and Communications
November 4, 2015

Detect and defend against pathogens

Understanding factors, such as the receptor TLR9, that detect and defend against pathogens may lead to therapeutic approaches that promote an effective immune response to treat infections.
By Leigh MacMillan
October 21, 2015

Biomarker for intestinal tumors

A new marker could be useful for diagnosing and treating neuroendocrine tumors of the small intestines.
By Leigh MacMillan
October 16, 2015

Healing without scarring

Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer.
By Sanjay Mishra
October 1, 2015

Tolerating a transplant

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.
By Leigh MacMillan
1 … 16 17 18 19 20 … 26